Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Access/Strakan license agreement

Jan. 10, 1997

SIBIA Neurosciences/Aurora Biosciences drug discovery technology agreement

Jan. 10, 1997

Genetics Institute/Ontogeny functional genomics agreement

Jan. 10, 1997

Antibody-based collaborative agreement reached by CaT and Lilly

Jan. 10, 1997

Bristol-Myers Squibb/Cadus collaboration extended

Jan. 10, 1997

Sequana and Glaxo Wellcome alliance

Jan. 9, 1997

Progenitor's functional genomics program advances

Jan. 9, 1997

Drug discovery collaboration agreement signed by Houghten, Chugai

Jan. 9, 1997

Caliper Technologies technology useful in drug discovery

Jan. 8, 1997

Genzyme Transgenics, BASF forge agreement for transgenic production of biopharmaceuticals

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...